RSS feed

Publications by Torhild Warncke

13 publications found

Original articles

Namer B, Schmidt D, Eberhardt E, Maroni M, Dorfmeister E, Kleggetveit IP, Kaluza L, Meents J, Gerlach A, Lin Z, Winterpacht A, Dragicevic E, Kohl Z, Schüttler J, Kurth I, Warncke T, Jorum E, Winner B, Lampert A (2018)
Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors
EBioMedicine, 39, 401-408
DOI 10.1016/j.ebiom.2018.11.042, PubMed 30503201

Solheim O, Skalleberg J, Warncke T, Ørstavik K, Tropé C, Fosså SD (2018)
Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor
Acta Obstet Gynecol Scand, 98 (2), 240-249
DOI 10.1111/aogs.13477, PubMed 30289161

Kongsgaard UE, Fischer K, Pedersen TE, Bukholm IR, Warncke T (2016)
Complaints to the Norwegian System of Patient Injury Compensation 2001-14 following nerve blockade
Tidsskr Nor Laegeforen, 136 (23-24), 1989-1992
DOI 10.4045/tidsskr.16.0368, PubMed 28004547

Schou Bredal I, Smeby NA, Ottesen S, Warncke T, Schlichting E (2014)
Chronic pain in breast cancer survivors: comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain
J Pain Symptom Manage, 48 (5), 852-62
DOI 10.1016/j.jpainsymman.2013.12.239, PubMed 24703940

Jørum E, Warncke T, Stubhaug A (2003)
Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo
Pain, 101 (3), 229-235
DOI 10.1016/S0304-3959(02)00122-7, PubMed 12583865

Warncke T, Stubhaug A, Jørum E (2000)
Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man
Pain, 86 (3), 293-303
DOI 10.1016/S0304-3959(00)00260-8, PubMed 10812259

Warncke T, Stubhaug A, Jørum E (1997)
Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo
Pain, 72 (1-2), 99-106
DOI 10.1016/s0304-3959(97)00006-7, PubMed 9272793

Warncke T, Jørum E, Stubhaug A (1997)
Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action
Neurosci Lett, 227 (1), 1-4
DOI 10.1016/s0304-3940(97)00263-2, PubMed 9178844

Warncke T, Brennum J, ArendtNielsen L, Branebjerg PE (1996)
Effects of local and systemic ibuprofen on primary and secondary hyperalgesia in man
Curr. Ther. Res.-Clin. Exp., 57 (12), 937-949
DOI 10.1016/S0011-393X(96)80112-3

Warncke T, Breivik H, Vainio A (1994)
Treatment of cancer pain in Norway. A questionnaire study
Pain, 57 (1), 109-116
DOI 10.1016/0304-3959(94)90114-7, PubMed 8065787

Review articles

Jørum E, Warncke T, Ørstavik K (2013)
[Small-fibre neuropathy]
Tidsskr Nor Laegeforen, 133 (2), 179-83
DOI 10.4045/tidsskr.12.0160, PubMed 23344604

Other articles

Jørum E, Warncke T (2012)
[Treatment of chronic non-malignant pain]
Tidsskr Nor Laegeforen, 132 (22), 2474
DOI 10.4045/tidsskr.12.1246, PubMed 23338018

Theses

Warncke T (2001)
Neurophysiological studies of peripheral and central mechanisms of primary and secondary hyperalgesia: studies in humans with acute experimental and chronic neuropathic pain
Laboratory of Clinical Neurophysiology, Department of Neurology, Rikshospitalet, The National Hospital, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 011964707, ISBN 82-7722-144-4